Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

The discovery of CSMD1's role in epilepsy represents a crucial step forward in unravelling the genetic mysteries of epilepsy.

Research reveals childhood kidney cancer's complex genetic landscape, paving the way for innovative treatments. ...

A new study reveals that music can positively influence infants’ mood, helping soothe and uplift their emotional state.

Biomarkers reveal vital insights that could improve treatment strategies for aggressive prostate cancer, offering hope for ...

ASCO 2025 highlights a troubling trend: alcohol-related cancer deaths are increasing across the U.S., raising urgent public ...

FSSAI warns food businesses against using misleading ‘100%’ claims on labels and promotions, urging compliance to ensure ...

Men with two copies of the H63D gene variant face over double the risk of dementia, highlighting the need for gender-specific ...

TDB supports S3V Vascular in developing India’s first indigenous stroke treatment device, boosting affordable care and ...

Limiting global warming can save twice the amount of ice, reducing glacier loss and helping to slow the rise of global sea ...

Indian astronaut Shubhanshu Shukla will lead groundbreaking food and nutrition experiments aboard the ISS, advancing ...

Artificial intelligence tool allows automated assessment of facial palsy severity, enhancing diagnosis and tracking, reports ...